Project Grant K01HG013968
Award Date
1/1/25
Completion Date
12/31/29
Dollars Obligated
$202K
Federal Agency
National Human Genome Research Institute
Federal Grant Program
93.172
Assistance Type
Project Grant
Place of Performance
Stanford, CA 94305, USA
Similar Awards
This federal Project Grant award for $605,280 was provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172). The grant supports a study on the ethical challenges that arise in patient-focused drug development (PFDD) for rare diseases, with the objective of gaining a multi-perspective account of these challenges and developing tools to manage them.
The three-year project, led by The Leland Stanford Junior University, involves...
This federal Project Grant award, with ID K01HG013687, was provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research (CFDA 93.172) program. The $205,418 grant aims to promote access to payment pathways for emerging molecular diagnostics (MDx) and address disparities in precision medicine implementation. The key objectives are to: 1) analyze patient-level factors associated with different MDx payment pathways, 2) define institution-level resources that...
This Project Grant award from the National Human Genome Research Institute (NHGRI), funded under the Human Genome Research program (CFDA 93.172), aims to characterize how adults with childhood-onset genetic conditions, specifically cystic fibrosis (CF), plan for their futures amid prognostic uncertainty. The $174,302 award supports qualitative research to describe how CF patients conceptualize their evolving prognoses and make future-oriented decisions, as well as how CF clinicians...
This Project Grant award from the National Human Genome Research Institute (NHGRI), under the Human Genome Research program (CFDA 93.172), will investigate ethical and policy challenges facing the gene therapy ecosystem. The $1,149,164 award to the Hastings Center Inc., a leading non-profit bioethics research institute, will analyze documents from federal and state policymakers, conduct surveys with physicians, and perform in-depth interviews with experts across five domains related to gene...
This federal Project Grant award, funded by the National Human Genome Research Institute (NHGRI) under the Human Genome Research (CFDA 93.172) program, aims to develop a practical framework of principles to guide ongoing policy development around variant reinterpretation, reclassification, and recontact in the field of medical genetics.
The $812,957 award to the University of Texas Southwestern Medical Center will achieve this through a three-part qualitative study involving focus groups, a...
This National Science Foundation project grant of $156,238 awarded on January 1, 2023 will fund research at Colorado State University to develop analytical tools combining heterogeneous genetic and molecular data sources to identify genetic modifiers of Parkinson's disease. Under the Mathematical and Physical Sciences program (CFDA 47.049), the researchers will use a hierarchical three-group mixture model to probabilistically model genes as null, deleterious, or beneficial based on...
This Project Grant awarded by the National Institute of Child Health and Human Development (CFDA 93.865 - Child Health and Human Development Extramural Research) provides $164,160 to support Dr. Gelineau-Morel's career development and research at Children's Mercy Hospital in Kansas City, Missouri. The primary objectives are to:
Determine the impact of CYP2D6 and CYP2C19 genotypes on exposure to the drug trihexyphenidyl (THP) and its enantiomers in children with dystonia and cerebral...
This federal Project Grant award for $162,461, provided by the National Human Genome Research Institute (NHGRI) under the Human Genome Research program (CFDA 93.172), supports an integrated multimodal phenotyping study of zebrafish models of human cognitive disorders. The University of Utah is the prime awardee and will leverage their expertise in single-cell biology, data science, and developmental biology to rapidly generate and characterize knockouts of 61 transcriptional regulators...
The Project Grant award R35GM155127, totaling $382,090, was provided by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The primary focus of this 5-year award to the University of Wisconsin - Madison is to investigate the role of human-specific genetic haplotype diversity in cell fate commitment and the maintenance of cell states. The research strategy involves utilizing induced pluripotent stem cells...
This $143,135 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) aims to investigate the role of short tandem repeat (STR) expansions in the development and progression of Alzheimer's disease (AD). The principal investigator will utilize existing whole genome sequencing data from over 11,000 AD cases and controls to test whether STR expansions correlate with age of onset and rate of disease progression (Aim 1). They will then assess somatic STR instability...